Amitriptyline vs nomifensineQuality of life · people with epilepsy and depression1 finding from 1 reviewAntidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Venlafaxine vs no treatmentQuality of life · people with epilepsy and depression1 finding from 1 reviewAntidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Intervention not reportedQuality of life · people with epilepsy and depression1 finding from 1 reviewAntidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Paroxetine vs doxepinQuality of life · people with epilepsy and depression1 finding from 1 reviewAntidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes onlyno estimate extracted0 studies · 0 participantsGRADE not reported
Selective serotonin reuptake inhibitors vs cognitive behavioural therapyPost‐treatment quality of life (QOLIE‐31 score, which has a range of 0‐200, with higher score indicates better quality of life) ( · people with epilepsy and depression1 finding from 1 reviewAntidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes onlyno estimate extracted15 participantsVery low
Sertraline vs cognitive behavioural therapyQuality of life (QOLIE‐89) (1‐ to 3‐month periods) · people with epilepsy and depression1 finding from 1 reviewAntidepressants for people with epilepsy and depression 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 118 participantsModerate